Filing Flows › DataMeds AI (MEDS) › Q1 2026 › vs Q1 2025
DataMeds AI (MEDS) Q1 2026 vs Q1 2025 (year over year)
DataMeds AI's revenue fell $9.3M (-86%) from $10.9M in Q1 2025 to $1.6M in Q1 2026. The biggest changes: Product −$10.4M (-98%); Pharmacy Retail Sales +$1.0M (+889%); Third Party Logistics Services +$119K (+148%).
DataMeds AI, Q1 2026: revenue $1.6M (-86% year over year), operating margin -385.7%, net loss $7.7M, operating cash flow −$3.4M. The chart draws each line against Q1 2025, the increases inside each band.
Every line
| Line | Q1 2026 | Q1 2025 | Change | % |
|---|---|---|---|---|
| Pharmacy Retail Sales | $1.1M | $115K | $1.0M | +889% |
| Product | $226K | $10.7M | −$10.4M | -98% |
| Third Party Logistics Services | $199K | $80K | $119K | +148% |
| Revenue | $1.6M | $10.9M | −$9.3M | -86% |
| Net loss | $7.7M | $32.4M | −$24.7M | -76% |
| Costs & expenses | $9.3M | $43.3M | −$34.0M | -79% |
| Operating costs | $7.6M | $42.2M | −$34.6M | -82% |
| Interest & other, net | $1.7M | $1.1M | $645K | +60% |
| Cost of revenue | $1.4M | $10.2M | −$8.8M | -86% |
| Sales & marketing | $960K | $65K | $895K | 15× |
| General & admin | $4.9M | $31.2M | −$26.3M | -84% |
| Other operating costs | $357K | $803K | −$446K | -56% |
| Operating cash sources | $7.7M | $32.4M | −$24.7M | -76% |
| Depreciation & amortization | $357K | $803K | −$446K | -56% |
| Share-based compensation | $1.4M | $27.8M | −$26.4M | -95% |
| Working capital & other | $2.6M | $2.5M | $108K | +4% |
| Cash used in operations | $3.4M | $1.3M | $2.1M | +153% |
| Net loss absorbed | $7.7M | $32.4M | −$24.7M | -76% |
Questions
How much did DataMeds AI's revenue grow year over year in Q1 2026?
DataMeds AI's revenue fell $9.3M (-86%) from $10.9M in Q1 2025 to $1.6M in Q1 2026.
What drove DataMeds AI's revenue change in Q1 2026?
Product −$10.4M (-98%); Pharmacy Retail Sales +$1.0M (+889%); Third Party Logistics Services +$119K (+148%).